Last reviewed · How we verify
Fecal Microbiota Transplant — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Fecal Microbiota Transplant (Fecal Microbiota Transplant) — Massachusetts General Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Fecal Microbiota Transplant TARGET | Fecal Microbiota Transplant | Massachusetts General Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Fecal Microbiota Transplant CI watch — RSS
- Fecal Microbiota Transplant CI watch — Atom
- Fecal Microbiota Transplant CI watch — JSON
- Fecal Microbiota Transplant alone — RSS
Cite this brief
Drug Landscape (2026). Fecal Microbiota Transplant — Competitive Intelligence Brief. https://druglandscape.com/ci/fecal-microbiota-transplant. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab